Mobile

A CUMULATIVE DOSE RESPONSE STUDY TO EVALUATE THE THERAPEUTIC EQUIVALENCE OF A NEW SALMETEROL INHALATION AEROSOL CONTAINING A REPLACEMENT HFA PROPELLANT IN A PRESSURISED METERED DOSE INHALER AND EXIST...

Update Il y a 4 ans
Reference: EUCTR2005-004744-32

A CUMULATIVE DOSE RESPONSE STUDY TO EVALUATE THE THERAPEUTIC EQUIVALENCE OF A NEW SALMETEROL INHALATION AEROSOL CONTAINING A REPLACEMENT HFA PROPELLANT IN A PRESSURISED METERED DOSE INHALER AND EXISTING SALMETEROL–CFC PRODUCT

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

The primary aim of the study is: To assess the therapeutic equivalence of a new salmeterol HFA-134a formulation compared to a reference salmeterol CFC formulation given in a cumulative dose design.

Inclusion criteria

  • asthma bronchiale

Links